MANHASSET, N.Y.--(BUSINESS WIRE)--The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research, its new President-Elect.

纽约曼哈塞特（商业新闻）——国际软骨再生与关节保存学会（ICRS）任命丹尼尔·格兰德（DanielA.Grande）博士为研究服务助理副总裁，费恩斯坦医学研究院（Feinstein Institutes for Medical research）分子医学和整形外科教授，为其新任总裁。

Dr. Grande will serve a two-year term, followed by an additional two-year term as the esteemed past president on the ICRS Executive Board..

Grande博士将任期两年，然后再连任两年，担任ICRS执行委员会尊敬的前任主席。。

Dr. Grande, renowned for his significant contributions to cartilage repair and regeneration, will lead the ICRS in its mission to advance science and education in preventing and treating cartilage injuries. His expertise and leadership will help drive the society's initiatives and foster new collaborations among research professionals globally..

Grande博士以对软骨修复和再生的重大贡献而闻名，他将领导ICRS推进预防和治疗软骨损伤的科学和教育。他的专业知识和领导力将有助于推动该协会的举措，并促进全球研究专业人员之间的新合作。。

'For more than thirty years, I have focused my research on cartilage repair to advance our understandings and find new treatments for our patients,” said Dr. Grande, professor at the Feinstein Institutes' Institute of Bioelectronic Medicine. 'I am honored and excited to serve as the President-Elect of the International Cartilage Regeneration & Joint Preservation Society.

范斯坦研究所生物电子医学研究所教授格兰德博士说：“三十多年来，我一直将研究重点放在软骨修复上，以增进我们的理解，并为患者找到新的治疗方法。”作为国际软骨再生与关节保存协会的当选主席，我感到荣幸和兴奋。

I look forward to working closely with the ICRS community to further our shared goals and continue advancing the cartilage repair and regeneration field.'.

我期待着与ICRS社区密切合作，以推进我们的共同目标，并继续推进软骨修复和再生领域。”。

Dr. Grande is a pioneer in cell-based therapies for articular cartilage repair. His research led to the FDA-approved autologous chondrocyte implantation, now the standard treatment for focal cartilage defects. While initially focusing on cartilage repair, Dr. Grande has broadened his expertise to include tissue engineering, stem cells, biomaterials, and biomechanics, exploring areas like the meniscus, intervertebral disc, tendon, and bone and the emerging field of 3D bioprinting..

Grande博士是关节软骨修复细胞疗法的先驱。他的研究导致FDA批准自体软骨细胞植入，现在是局灶性软骨缺损的标准治疗方法。在最初专注于软骨修复的同时，Grande博士扩大了他的专业知识，包括组织工程，干细胞，生物材料和生物力学，探索了半月板，椎间盘，肌腱和骨骼等领域以及新兴的3D生物打印领域。。

He has published more than 100 peer-reviewed articles in top journals, including Nature Reviews Rheumatology and Clinical Orthopedics, and has contributed to book chapters and editorials. Recently, his lab pioneered 3D bioprinting applications and collaborated with other departments on biomaterials and tracheal reconstruction.

他在顶级期刊上发表了100多篇同行评议文章，包括《自然评论》、《风湿病学》和《临床骨科》，并为书籍章节和社论做出了贡献。最近，他的实验室开创了3D生物打印应用，并与其他部门合作进行生物材料和气管重建。

Most recently, he published in the Journal of Cartilage & Joint Preservation, looking at extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) believed to help in cartilage regeneration, and helped redefine orthobiologics in the Open Journal of Regenerative Medicine..

最近，他在《软骨与关节保存杂志》上发表了文章，研究了间充质干细胞（MSCs）的细胞外囊泡（EVs），这些囊泡被认为有助于软骨再生，并在《再生医学开放杂志》上重新定义了正生物制剂。。

“Dr. Grande founded the orthopedic research lab at the Feinstein Institutes and continues to explore innovative regenerative therapies, including stem cells and 3D bioprinting,' said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

“格兰德博士在范斯坦研究所成立了骨科研究实验室，并继续探索创新的再生疗法，包括干细胞和3D生物打印，”范斯坦研究所总裁兼首席执行官凯文·J·特雷西（KevinJ.Tracey）医学博士和卡奇家族医学研究杰出主席说道。

“On behalf of our 5,000 researchers and staff, we congratulate Dr. Grande on his election to the ICRS and look forward to his continued leadership.”.

“我们代表我们的5000名研究人员和工作人员，祝贺Grande博士当选为ICRS，并期待他继续发挥领导作用。”。

The ICRS is a prominent international society dedicated to the advancement of cartilage research, focusing on the prevention and treatment of cartilage injuries. With a network of leading experts and researchers from around the world, the society plays a pivotal role in promoting innovative research, education, and clinical practice in the field of cartilage repair..

ICRS是一个杰出的国际学会，致力于软骨研究的进步，专注于软骨损伤的预防和治疗。该协会拥有来自世界各地的顶尖专家和研究人员网络，在促进软骨修复领域的创新研究、教育和临床实践方面发挥着关键作用。。

About the Feinstein Institutes

关于范斯坦学院

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine.

范斯坦医学研究院（Feinstein Institutes for Medical Research）是纽约州最大的医疗保健提供者和私人雇主Northwell Health研究院的所在地。范斯坦研究所拥有50个研究实验室、3000个临床研究和5000名研究人员和工作人员，通过其行为科学、生物电子医学、癌症、卫生系统科学和分子医学五个研究所提高了医学创新的标准。

We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn..

我们在遗传学、肿瘤学、大脑研究、心理健康、自身免疫方面取得了突破，并且是生物电子医学的全球科学领导者，生物电子医学是一个有可能彻底改变医学的新科学领域。有关我们如何产生治疗疾病的知识的更多信息，请访问http://feinstein.northwell.edu并在LinkedIn上关注我们。。